IL10 and neoplasm: Furthermore, regulatory T cells (Tregs) are typically immunosuppressive within the TME, impeding the host’s anti-tumor immune response by secreting inhibitory cytokines such as IL-10, TGF-β, and IL-35, and have emerged as significant therapeutic targets in contemporary anti-tumor immune interventions (75).